High volatility in T2 Biosystems stock price on Tuesday which ended trading at $0.339StockInvest.us, 2 months ago
The T2 Biosystems stock price fell by -26.13% on the last day (Tuesday, 19th Sep 2023) from $0.459 to $0.339. During the last trading day the stock fluctuated 24.49% from a day low at $0.321 to a day high of $0.400. The price has fallen in 6 of the last 10 days and is down by -2.02% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -273 million shares and in total, 130 million shares were bought and sold for approximately $44.21 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.279 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.Given the current short-term trend, the stock is expected to rise 107.02% during the next 3 months and, with a 90% probability hold a price between $0.578 and $1.52 at the end of this 3-month period.
There are mixed signals in the stock today. The T2 Biosystems stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.354. On a fall, the stock will find some support from the short-term average at $0.310. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, August 15, 2023, and so far it has fallen -42.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
T2 Biosystems finds support from accumulated volume at $0.327 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0787 between high and low, or 24.49%. For the last week, the stock has had daily average volatility of 22.70%.
T2 Biosystems holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.Check full T2 Biosystems forecast and analysis here.